Market is projected to reach USD 86 million by 2031, exhibiting a compound annual growth rate (CAGR) of 4.5% during the forecast period (2025–2032).

Interferon Alpha-2a Biosimilar market is projected to decline to USD 50.2 million by 2031 from USD 71.4 million in 2025, reflecting a compound annual growth rate (CAGR) of -11.9% during the forecast period.

The global antivenom market is projected to reach USD 1,288 million by 2031, expanding at a compound annual growth rate (CAGR) of 4.5% during the forecast period (2025–2032).

Paclitaxel market is projected to reach USD 2.09 billion by 2031, expanding at a compound annual growth rate (CAGR) of 8.9% during the forecast period (2025–2032).

Botox market is poised for robust expansion, growing from USD 5.17 billion in 2024 to USD 10.30 billion by 2031, at a CAGR of 10.6% during the forecast period.

Quetiapine Fumarate market was valued at USD 142 million in 2024 and is forecasted to reach USD 121 million by 2031, registering a CAGR of -2.4% during the forecast period.

Market is expected to grow steadily to USD 39.2 billion by 2030, registering a compound annual growth rate (CAGR) of 5.2% during the forecast period.

According to a new report from Intel Market Research, Global ATP consumables for healthcare market is undergoing strong growth across

DefinitionThe Management Consulting Services Market encompasses a wide range of professional advisory solutions aimed at improving business performance, enhancing operational